ProShare Advisors LLC

Position in PRME — Prime Medicine, Inc.

CIK 1357955 BETHESDA, MD

Position in PRME

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$67,316

-$12,612 QoQ

Shares Held

18,243

-20.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#122

of 186 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. PRME ranks #143 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$67,316	18,243	-20.6%	Shares	Sole	2026-08-11
2026-03-31	$79,928	22,968	-12.2%	Shares	Sole	2026-04-27
2025-12-31	$90,768	26,158	+37.0%	Shares	Sole	2026-02-06
2025-09-30	$105,808	19,099	+13.2%	Shares	Sole	2025-11-06
2025-06-30	$41,671	16,871	-7.3%	Shares	Sole	2025-08-07
2025-03-31	$36,206	18,194	-18.0%	Shares	Sole	2025-05-08
2024-12-31	$64,783	22,186	+24.6%	Shares	Sole	2025-02-14
2024-09-30	$68,928	17,811	+40.2%	Shares	Sole	2024-11-14
2024-06-30	$65,313	12,707	-16.8%	Shares	Sole	2024-08-13
2024-03-31	$106,932	15,276	+19.8%	Shares	Sole	2024-05-08
2023-12-31	$113,018	12,756	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.